{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:59Z","timestamp":1790767559837,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jaad.2023.11.024","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:26:56Z","timestamp":1700800016000},"page":"585-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nail psoriasis and nail lichen planus: Updates on diagnosis and management"],"prefix":"10.1016","volume":"90","author":[{"given":"Jonathan K.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Iorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca M.","family":"Piraccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris G.","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/07853890.2022.2044511","article-title":"Optimal diagnosis and management of common nail disorders","volume":"54","author":"Lee","year":"2022","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.jaad.2023.11.024_bib2","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1111\/jdv.18435","article-title":"How to choose a systemic treatment for moderate-to-severe nail psoriasis","volume":"36","author":"Rigopoulos","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaad.2022.12.031","article-title":"The untold burden of isolated nail psoriasis: delayed diagnosis and significant risk of psoriatic arthritis in a retrospective study at an academic center","volume":"88","author":"Chang","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000512688","article-title":"The impact of nail psoriasis and treatment on quality of life: a systematic review","volume":"7","author":"Stewart","year":"2021","journal-title":"Skin Appendage Disord"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.det.2020.12.002","article-title":"Review of nail lichen planus: epidemiology, pathogenesis, diagnosis, and treatment","volume":"39","author":"Gupta","year":"2021","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib6","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jaad.2018.11.065","article-title":"Nail lichen planus: a true nail emergency","volume":"80","author":"Lipner","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.annder.2022.01.010","article-title":"Nail lichen planus: a review of clinical presentation, diagnosis and therapy","volume":"149","author":"Grover","year":"2022","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.det.2020.12.014","article-title":"Management of nail psoriasis","volume":"39","author":"Rigopoulos","year":"2021","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2019.01.072","article-title":"Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus","volume":"81","author":"Rigopoulos","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jaad.2020.02.056","article-title":"Isolated nail lichen planus: an expert consensus on treatment of the classical form","volume":"83","author":"Iorizzo","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.024_bib11","first-page":"731","article-title":"A major win for the treatment of nail psoriasis","volume":"16","author":"Lipner","year":"2017","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40257-023-00786-4","article-title":"Efficacy and safety of nail psoriasis targeted therapies: a systematic review","volume":"24","author":"Hwang","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000507298","article-title":"Small molecules and biologics in the treatment of nail psoriasis","volume":"6","author":"Rigopoulos","year":"2020","journal-title":"Skin Appendage Disord"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2340\/00015555-3098","article-title":"Nail psoriasis: an updated review and expert opinion on available treatments, including biologics","volume":"99","author":"Bardazzi","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2023.11.024_bib15","first-page":"25","article-title":"Optimal management of nail disease in patients with psoriasis","volume":"5","author":"Piraccini","year":"2015","journal-title":"Psoriasis (Auckl)"},{"issue":"11","key":"10.1016\/j.jaad.2023.11.024_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/cup.13334","article-title":"Clinical and histological spectrum of nail psoriasis: a cross-sectional study","volume":"45","author":"Kaul","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1016\/j.jaad.2023.11.024_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/1744666X.2023.2215987","article-title":"Updates in treatment and impact of nail psoriasis","volume":"19","author":"Iorizzo","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib18","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.det.2021.01.002","article-title":"Nail disorders: diagnosis and management","volume":"39","author":"Lipner","year":"2021","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.det.2018.12.004","article-title":"What\u2019s new in nail disorders","volume":"37","author":"Maddy","year":"2019","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.12788\/cutis.0311","article-title":"The top 100 most-cited articles on nail psoriasis: a bibliometric analysis","volume":"108","author":"Malik","year":"2021","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2023.11.024_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdcr.2021.09.009","article-title":"Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine","volume":"17","author":"Ricardo","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib22","article-title":"Recommendations for treatment of nail psoriasis during the COVID-19 pandemic","volume":"33","author":"Ricardo","year":"2020","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14276","article-title":"Trends in psoriasis treatment 2005 to 2018: declining phototherapy utilization and concomitant increased use of biologics","volume":"33","author":"Do","year":"2020","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year","volume":"58","author":"Rich","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaad.2018.03.062","article-title":"Onychomycosis: clinical overview and diagnosis","volume":"80","author":"Lipner","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","article-title":"Onychomycosis: treatment and prevention of recurrence","volume":"80","author":"Lipner","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.11.024_bib27","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2147\/CCID.S362635","article-title":"Updated perspectives on the diagnosis and management of onychomycosis","volume":"15","author":"Falotico","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.11.024_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/jof9070710","article-title":"Isolation of terbinafine-resistant Trichophyton rubrum from onychomycosis patients who failed treatment at an Academic Center in New York, United States","volume":"9","author":"Hwang","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2005.06862.x","article-title":"Diagnosis of nail psoriasis: importance of biopsy and histopathology","volume":"153","author":"Grover","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0378-6323.95443","article-title":"Role of nail biopsy as a diagnostic tool","volume":"78","author":"Grover","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/bjd.15026","article-title":"Natural history of isolated nail psoriasis and its role as a risk factor for the development of psoriatic arthritis: a single-centre cross-sectional study","volume":"176","author":"Balestri","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib32","first-page":"138","article-title":"Clinical pearl: early diagnosis of nail psoriasis and psoriatic arthritis","volume":"99","author":"Lipner","year":"2017","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2023.11.024_bib33","doi-asserted-by":"crossref","unstructured":"Chang MJ, Lee D, Desai AD, Lipner SR. Disparities in time to diagnosis and disease severity in skin of colour patients with nail psoriasis: a retrospective analysis. J Eur Acad Dermatol Venereol. 2023;10.1111\/jdv.19110. https:\/\/doi.org\/10.1111\/jdv.19110. Online ahead of print.","DOI":"10.1111\/jdv.19110"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib34","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1111\/jdv.18611","article-title":"No Association of Metabolic Syndrome with isolated nail psoriasis in a retrospective single-centre academic study","volume":"37","author":"Miller","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2023.11.024_bib35","series-title":"Advances in Nail Disease and Management","first-page":"129","article-title":"Latest research in nail psoriasis","author":"Pasch","year":"2021"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-021-08896-9","article-title":"Challenge of nail psoriasis: an update review","volume":"61","author":"Ji","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2023.11.024_bib37","series-title":"StatPearls [Internet]","article-title":"Onychoscopy","author":"Sathe","year":"2023"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000508165","article-title":"Dermoscopic features of nail psoriasis: an observational, analytical study","volume":"6","author":"Chauhan","year":"2020","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000524109","article-title":"Dermoscopic features of nail psoriasis: revisited","volume":"8","author":"Yorulmaz","year":"2022","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2007.11.026","article-title":"Videodermoscopy of the hyponychium in nail bed psoriasis","volume":"58","author":"Iorizzo","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.11.024_bib41","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/1346-8138.13438","article-title":"Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis","volume":"43","author":"Errichetti","year":"2016","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/ced.13809","article-title":"Linear nail bed dyschromia: a distinctive dermoscopic feature of nail lichen planus","volume":"44","author":"Grover","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib43","first-page":"11","article-title":"Dermoscopy: the ultimate tool for diagnosis of nail psoriasis? A review of the diagnostic utility of dermoscopy in nail psoriasis","volume":"32","author":"Yorulmaz","year":"2023","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jaad.2023.11.024_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2023.104476","article-title":"Nailfold capillaroscopy as diagnostic test in patients with psoriasis and psoriatic arthritis: a systematic review","volume":"147","author":"Lazar","year":"2023","journal-title":"Microvasc Res"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.25259\/IJDVL_514_20","article-title":"Nail-fold capillaroscopy for the dermatologists","volume":"88","author":"Grover","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"9","key":"10.1016\/j.jaad.2023.11.024_bib46","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.3390\/ijerph19095611","article-title":"Usefulness of ultrasound examination in the assessment of the nail apparatus in psoriasis","volume":"19","author":"Krajewska-W\u0142odarczyk","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib47","doi-asserted-by":"crossref","first-page":"854","DOI":"10.25259\/IJDVL_894_2022","article-title":"Enthesopathy in patients with nail psoriasis \u2013 a cross-sectional evaluation of clinical, onychoscopic and ultrasonographic features","volume":"89","author":"Bhoi","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/exd.14572","article-title":"Imaging of the nail unit in psoriatic patients: A systematic scoping review of techniques and terminology","volume":"31","author":"Ortner","year":"2022","journal-title":"Exp Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.11.024_bib49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/jdv.12330","article-title":"Confocal microscopy for healthy and pathological nail","volume":"28","author":"Cinotti","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000499348","article-title":"Short-term correlation of the psoriasis area severity index, the nail psoriasis area severity index, and the dermatology life quality index, before and after treatment, in patients with skin and nail psoriasis","volume":"5","author":"Prevezas","year":"2019","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib51","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/ajd.13412","article-title":"Development and validation of a new method for potential use of Psoriasis Area and Severity Index in teledermatology","volume":"62","author":"Wu","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2023.11.024_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-27276-9_3","article-title":"Review of teledermatology: lessons learned from the COVID-19 pandemic","author":"Hwang","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000533386","article-title":"Bullous lichen planus of the nails: a case report and review of the literature","volume":"15","author":"Hwang","year":"2023","journal-title":"Case Rep Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib53","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/ajd.13454","article-title":"Nail dermatoscopic (onychoscopic) features of nail lichen planus: a cross-sectional study","volume":"62","author":"Kharghoria","year":"2021","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib54","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3390\/ijerph19063392","article-title":"Update on diagnosis and management of onychophagia and onychotillomania","volume":"19","author":"Lee","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40257-017-0289-6","article-title":"Onychotillomania: diagnosis and management","volume":"18","author":"Halteh","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/09546634.2016.1200711","article-title":"Onychophagia: a nail-biting conundrum for physicians","volume":"28","author":"Halteh","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/12034754231168838","article-title":"Nail lichen planus with overlying contact dermatitis","volume":"27","author":"Hwang","year":"2023","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archdermatol.2010.43","article-title":"In situ amelanotic melanoma of the nail unit mimicking lichen planus: report of 3 cases","volume":"146","author":"Andr\u00e9","year":"2010","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cup.13783","article-title":"Histopathological evaluation of nail lichen planus: a cross-sectional study","volume":"48","author":"Kharghoria","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00000372-199412000-00006","article-title":"Nail matrix hypergranulosis","volume":"16","author":"Fanti","year":"1994","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib61","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-4632.2011.05283.x","article-title":"Dermatoscopy of nail lichen planus","volume":"52","author":"Nakamura","year":"2013","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2023.11.024_bib62","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/ijd.16167","article-title":"Description of the most severe signs in nail lichen planus: a strategy to contribute to the diagnosis of the severe stage","volume":"61","author":"Ceccarelli","year":"2022","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib63","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4103\/idoj.idoj_299_21","article-title":"Nail lichen planus severity index (NALSI): a novel severity score for nail lichen planus","volume":"13","author":"Grover","year":"2022","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/idoj.idoj_222_21","article-title":"Topical tretinoin in the treatment of nail psoriasis","volume":"13","author":"Grover","year":"2022","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib65","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaad.2021.12.017","article-title":"Poor coverage of psoriasis biologics in a cross-sectional analysis of Medicaid formularies","volume":"87","author":"Falotico","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib66","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/ced.15110","article-title":"A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis","volume":"47","author":"Starace","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib67","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ced.13087","article-title":"Role of nail bed methotrexate injections in isolated nail psoriasis: conventional drug via an unconventional route","volume":"42","author":"Grover","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijdvl.IJDVL_73_16","article-title":"Intramatricial injections for nail psoriasis: an open-label comparative study of triamcinolone, methotrexate, and cyclosporine","volume":"84","author":"Mittal","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"10.1016\/j.jaad.2023.11.024_bib69","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1365-4632.2006.02958.x","article-title":"The nail and Koebner-like phenomenon","volume":"45","author":"Daniel","year":"2006","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib70","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.jaad.2023.05.005","article-title":"Remedy for split nail using silk wraps and gel resin","volume":"89","author":"Hwang","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09546634.2020.1749546","article-title":"Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials","volume":"33","author":"Elewski","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib72","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/jdv.17055","article-title":"Treatment of nail psoriasis with brodalumab: an open-label unblinded study","volume":"35","author":"Gregoriou","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jdv.18572","article-title":"Real-world effectiveness and safety of tildrakizumab in long-term treatment of plaque psoriasis: results from the non-interventional, prospective, multicentre study TILOT","volume":"37","author":"Tsianakas","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2023.11.024_bib74","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3390\/jcm11092631","article-title":"Efficacy of tildrakizumab for the treatment of difficult-to-treat areas: scalp, nail, palmoplantar and genital psoriasis","volume":"11","author":"Galluzzo","year":"2022","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.024_bib75","doi-asserted-by":"crossref","first-page":"914","DOI":"10.36849\/JDD.6828","article-title":"Nail psoriasis improvement during tildrakizumab therapy: a real-life experience","volume":"21","author":"Brunasso","year":"2022","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/annrheumdis-2021-221019","article-title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial","volume":"81","author":"Kristensen","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00403-021-02200-7","article-title":"Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period","volume":"314","author":"Megna","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.jaad.2023.11.024_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15524","article-title":"Risankizumab treatment in psoriasis patients who failed anti-IL17: a 52-week real-life study","volume":"35","author":"Megna","year":"2022","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.jaad.2023.11.024_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15506","article-title":"Anti-IL23for nail psoriasis in real life: results of efficacy and safety during a 52-week period","volume":"35","author":"Trovato","year":"2022","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib80","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1080\/09546634.2022.2081655","article-title":"Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study","volume":"33","author":"Megna","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib81","doi-asserted-by":"crossref","first-page":"s49","DOI":"10.25251\/skin.6.supp.49","article-title":"Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in scalp, nail, and palmoplantar psoriasis: subgroup analyses of the phase 3 POETYK PSO-1 and PSO-2 trials","volume":"6","author":"Blauvelt","year":"2022","journal-title":"SKIN J Cutaneous Med"},{"key":"10.1016\/j.jaad.2023.11.024_bib84","first-page":"1766","article-title":"AB1089 Bimekizumab efficacy in high-impact areas for patients with moderate to severe plaque psoriasis: pooled results through two years from the BE SURE and BE RADIANT phase 3 trials","volume":"82","author":"Merola","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa2102388","article-title":"Bimekizumab versus adalimumab in plaque psoriasis","volume":"385","author":"Warren","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jaad.2023.11.024_bib87","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s40265-022-01796-y","article-title":"Deucravacitinib: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaad.2021.01.024","article-title":"Small molecule inhibitors and biologics in treating nail psoriasis: a systematic review and network meta-analysis","volume":"85","author":"Huang","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib90","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaad.2021.02.057","article-title":"Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: a network meta-analysis of clinical trial data","volume":"85","author":"Shear","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.11.024_bib91","first-page":"247","article-title":"Latest advances for the treatment of chronic plaque psoriasis with biologics and oral small molecules","volume":"15","author":"Bellinato","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.jaad.2023.11.024_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175668","article-title":"Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: a focus on targeting major inflammatory cytokine pathways","volume":"947","author":"Kadagothy","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib93","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s13555-021-00554-4","article-title":"Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of A 54-week randomized double-blind placebo-controlled PLANETA clinical trial","volume":"11","author":"Puig","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib94","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/14740338.2023.2227560","article-title":"Safety of current systemic therapies for nail psoriasis","volume":"22","author":"Hwang","year":"2023","journal-title":"Expert Opin Drug Saf"},{"issue":"19","key":"10.1016\/j.jaad.2023.11.024_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911128","article-title":"Biological treatments for pediatric psoriasis: state of the art and future perspectives","volume":"23","author":"Diotallevi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib96","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.det.2020.12.011","article-title":"Nail psoriasis in older adults: epidemiology, diagnosis, and topical therapy","volume":"39","author":"Ricardo","year":"2021","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2023.11.024_bib97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.det.2020.12.012","article-title":"Nail psoriasis in older adults: intralesional, systemic, and biological therapy","volume":"39","author":"Ricardo","year":"2021","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.jaad.2023.11.024_bib98","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1111\/ijd.16333","article-title":"Where are the older adults? Age distribution of nail psoriasis randomized clinical trials\u2019 participants: a systematic review","volume":"61","author":"Ricardo","year":"2022","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000520469","article-title":"Racial, ethnic, and sex disparities in nail psoriasis clinical trials: a systematic review","volume":"8","author":"Ricardo","year":"2022","journal-title":"Skin Appendage Disord"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib100","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.jaad.2022.01.043","article-title":"Under-representation of racial and ethnic minorities in nail psoriasis randomized clinical trials: a call to action","volume":"86","author":"Ricardo","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.11.024_bib101","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1111\/ijd.16253","article-title":"Prioritization of race and ethnicity reporting and recruitment of diverse participants","volume":"62","author":"Chang","year":"2023","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib102","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/pde.15295","article-title":"Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population","volume":"40","author":"Iorizzo","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.024_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15627","article-title":"A pediatric case of recalcitrant nail psoriasis successfully treated with a single dose of intralesional triamcinolone acetonide","volume":"35","author":"Ricardo","year":"2022","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.jaad.2023.11.024_bib104","doi-asserted-by":"crossref","first-page":"715","DOI":"10.36849\/JDD.7093","article-title":"Racial disparities in primary therapy for newly diagnosed psoriasis patients","volume":"22","author":"Miller","year":"2023","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.11.024_bib105","article-title":"Recommendations for treatment of nail lichen planus during the COVID-19 pandemic","volume":"33","author":"Ricardo","year":"2020","journal-title":"Dermatol Ther"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.024_bib106","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1080\/09546634.2022.2116926","article-title":"JAK inhibitors in lichen planus: a review of pathogenesis and treatments","volume":"33","author":"Motamed-Sanaye","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.jaad.2023.11.024_bib107","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jid.2022.01.015","article-title":"Ruxolitinib cream in the treatment of cutaneous lichen planus: a prospective, open-label study","volume":"142","author":"Brumfiel","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib109","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamadermatol.2020.4555","article-title":"Tofacitinib as treatment for nail lichen planus associated with alopecia universalis","volume":"157","author":"Iorizzo","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.11.024_bib110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamadermatol.2021.5082","article-title":"Treatment of severe nail lichen planus with baricitinib","volume":"158","author":"P\u00fcnchera","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.11.024_bib111","article-title":"Platelet-rich-plasma: a\u00a0potential therapeutic tool for nail lichen planus","volume":"34","author":"Mokni","year":"2021","journal-title":"Dermatol\u00a0Ther"},{"issue":"3","key":"10.1016\/j.jaad.2023.11.024_bib112","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/JCAS.JCAS_156_20","article-title":"Intra-individual right-left comparative study of combined therapy of intramatricial triamcinolone and platelet-rich plasma vs. intramatricial triamcinolone only in lichen planus-associated nail dystrophy","volume":"14","author":"Rehman","year":"2021","journal-title":"J Cutan Aesthet Surg"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223032243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223032243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:31:18Z","timestamp":1759275078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223032243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0190962223032243"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.024","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nail psoriasis and nail lichen planus: Updates on diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}